NCT02834013 2026-06-03Nivolumab and Ipilimumab in Treating Patients With Rare TumorsNational Cancer Institute (NCI)Phase 2 Active not recruiting798 enrolled
NCT01869725 2021-09-22Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CTUniversity of IowaPhase 2 Completed68 enrolled 8 charts